ID: ALA145687

Max Phase: Preclinical

Molecular Formula: C19H19NO2

Molecular Weight: 293.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NC1(C(=O)c2ccccc2)CCCC1)c1ccccc1

Standard InChI:  InChI=1S/C19H19NO2/c21-17(15-9-3-1-4-10-15)19(13-7-8-14-19)20-18(22)16-11-5-2-6-12-16/h1-6,9-12H,7-8,13-14H2,(H,20,22)

Standard InChI Key:  FBUYXVGNXJYKNO-UHFFFAOYSA-N

Associated Targets(non-human)

Ecdysone receptor 281 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 293.37Molecular Weight (Monoisotopic): 293.1416AlogP: 3.61#Rotatable Bonds: 4
Polar Surface Area: 46.17Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.86CX LogD: 3.86
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.88Np Likeness Score: -0.46

References

1. Tice CM, Hormann RE, Thompson CS, Friz JL, Cavanaugh CK, Michelotti EL, Garcia J, Nicolas E, Albericio F..  (2003)  Synthesis and SAR of alpha-acylaminoketone ligands for control of gene expression.,  13  (3): [PMID:12565954] [10.1016/s0960-894x(02)00980-0]

Source